Open AccessCombining immunotherapy and epidermal growth factor receptor kinase inhibitors: worth the risk?
Author(s) -
Hira Latif,
Stephen V. Liu
Publication year - 2019
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2019.03.6
Subject(s) - immunotherapy , epidermal growth factor receptor , medicine , lung cancer , oncology , cancer research , receptor , cancer